March 2017 - Page 5 of 49 - NetworkNewsWire

ThursdayMar 16, 2017 8:30 am

Unique Cannabis-Pharma Companies Trailblazing the Medical Cannabis Industry

The cannabis industry has swiftly turned into a multi-billion dollar opportunity. In the United States, this market’s massive growth potential is being recognized as new states legalize marijuana for medical or recreational use. Industry experts forecast the U.S. cannabis market rounding $7 billion in 2016, while the annual sale of state-legal cannabis products is forecast to exceed $20 billion by 2020. Within this flourishing market, cannabis-pharma companies like India Globalization Capital (IGC) (IGC Profile), Zynerba Pharmaceuticals, Inc. (ZYNE), OWC Pharmaceutical Research Corp. (OWCP), Insys Therapeutics, Inc. (INSY) and GW Pharmaceuticals plc (GWPH) are carving lanes of unprecedented opportunities in the…

ThursdayMar 16, 2017 8:00 am

MGX Minerals (MGXMF): Engineering Partner Significantly Upgrades Brine Samples at Lithium Project in Alberta

The highly anticipated process of extracting lithium from petroleum brine water (known as “petrolithium”) is quickly advancing toward reality. MGX Minerals (OTC: MGXMF; CSE: XMG; FKT: 1MG), the innovator and sole proprietary technology holder of petrolithium, recently reported positive results of a lithium project operated by its engineering partner, Purlucid Treatment Solutions. Tasked with the challenge of upgrading bulk samples of petro lithium brines at its 132,000-hectare Sturgeon Lake Petro Lithium Project located at Fox Creek, Alberta, Purlucid over delivered - significantly increasing concentration levels and separating out excess minerals. Under the direction of Purlucid CEO Dr. Preston McEachern, the…

WednesdayMar 15, 2017 3:30 pm

Cellectar Biosciences, Inc. (NASDAQ: CLRB) Starts Presentation at 29th Annual ROTH Conference

Cellectar Biosciences (NASDAQ: CLRB) is engaged in the development of targeted phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. It offers CLR 131, a PDC radiotherapeutic product candidate currently being evaluated in a phase I study for the treatment of relapse or refractory multiple myeloma; CLR 125, a cancer-targeting radiotherapeutic is under pre-clinical investigation for the treatment of micrometastatic disease ; CLR 124, a cancer-targeting positron emission tomography (PET) imaging PDC for the selective detection of tumors and metastases in a broad range of cancers; and CLR 1502, a cancer-targeting NIR-fluorophore optical imaging PDC for intraoperative tumor…

WednesdayMar 15, 2017 3:30 pm

Command Center, Inc. (CCNI) Starts Presentation at 29th Annual ROTH Conference

Command Center (OTCQB: CCNI) provides flexible on-demand employment solutions for small to mid-sized businesses in the United States, primarily in the areas of light industrial, hospitality and event services. The company provides on-demand employees for manual labor, light industrial, and skilled trades applications. Through 63 field offices, the company provides employment annually for over 33,000 field team members working for 3,300 clients. For more information, visit the company’s website www.commandonline.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with…

WednesdayMar 15, 2017 3:20 pm

Extreme Networks, Inc. (NASDAQ: EXTR) Enters Asset Purchase Agreement for Avaya Networking, Subject To Bankruptcy Court Approval

Extreme Networks, Inc. (NASDAQ: EXTR) has entered into an asset purchase agreement for Avaya Networking, Inc. totaling $100 million, subject to adjustments. In January 2017, Avaya and certain of its subsidiaries filed for Chapter 11 bankruptcy in the Southern District of New York. Extreme Networks’ offer is subject to court approval. The company defined its offer in an 8K SEC filing on March 7, 2017 (http://nnw.fm/d4iOv). Extreme Networks, Inc. is a networking company based in San Francisco. It designs, builds and installs ethernet computer network products. It is a software-driven company that enables IT departments of clients to build stronger…

WednesdayMar 15, 2017 3:00 pm

Elio Motors, Inc. (ELIO) Starts Presentation at 29th Annual ROTH Conference

Elio Motors (OTC: ELIO) is engaged in manufacturing an ultra-high-mileage vehicle. The three-wheel Elio is engineered to attain a highway mileage rating of up to 84 mpg, while providing the comfort of amenities such as power windows, power door lock, air conditioning and cruise control, accompanied by the safety of multiple air bags and an aerodynamic, enclosed vehicle body. Elio was founded by car enthusiast Paul Elio in 2009 and its first manufacturing site will be in Shreveport, LA. For more information, visit the company’s website at www.eliomotors.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a…

WednesdayMar 15, 2017 3:00 pm

Regulus Therapeutics Inc. (NASDAQ: RGLS) Starts Presentation at 29th Annual Roth Conference

Regulus Therapeutics (NASDAQ: RGLS) is a biopharmaceutical company that focuses on the discovery and development of drugs that target RNAs to treat a broad range of diseases. The company uses its microRNA product platform to develop anti-miRs, which are chemically modified and single-stranded oligonucleotides. Its clinical development products include RG-101, a GalNAc-conjugated anti-miR targeting miR-122 to treat patients with hepatitis C virus infection; RG-012, an anti-miR targeting microRNA-21 for the treatment of Alport syndrome; and RG-125, a GalNAc-conjugated anti-miR targeting microRNA-103/107 to treat nonalcoholic steatohepatitis in patients with type 2 diabetes/pre-diabetes. For more information, visit the company’s website at www.regulusrx.com.…

WednesdayMar 15, 2017 3:00 pm

Eastside Distilling, Inc. (ESDI) Starts Presentation at 29th Annual ROTH Conference

Eastside Distilling (OTC: ESDI) develops, manufactures, produces and markets hand-crafted spirits in the United States. The company offers bourbon under the Burnside Bourbon and Oregon Oak Burnside Bourbon brand names; premium whiskey under the Barrel Hitch American Whiskey and Barrel Hitch Oregon Oaked Whiskey brand names; distinctive whiskey under the Cherry Bomb Whiskey and Marionberry Whiskey brand names; and rum under the Below Deck Silver Rum, Below Deck Spiced Rum, Below Deck Coffee Rum, and Below Deck Ginger Rum brand names. For more information, visit the company’s website at www.eastsidedistilling.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press…

WednesdayMar 15, 2017 3:00 pm

Monaker Group Inc (OTCQB:MKGI) Starts Presentation at 29th Annual Roth Conference

Monaker Group (OTC: MKGI) operates an online marketplace for the alternative lodging rental industry in Europe, Asia, South America, and the United States. The company provides activities and tours at the destinations for travelers through its Maupintour products, and employment solutions through NameYourFee.com website. The company was formerly known as Next 1 Interactive, Inc. and changed its name to Monaker Group, Inc. in June 2015. The company was founded in 2002 and is based in Weston, Florida. Monaker Group, Inc. is a subsidiary of Extraordinary Vacations Group Inc. For more information, visit the company’s website at www.monakergroup.com. About NetworkNewsWire NetworkNewsWire…

WednesdayMar 15, 2017 2:30 pm

Marina Biotech, Inc. (MRNA) Starts Presentation at 29th Annual Roth Conference

Marina Biotech (OTC: MRNA) discovers and develops nucleic acid-based therapeutics for rare and orphan diseases. The company’s portfolio includes single and double-stranded nucleic acid therapeutics, including siRNAs, microRNA mimics, antagomirs, and antisense compounds that are intended to trigger various RNA-based mechanisms of actions, such as RNA interference, microRNA replacement therapy, microRNA inhibition, and mRNA translational inhibition. It also focuses on patients with familial adenomatous polyposis, a rare hereditary disease; myotonic dystrophy, a disease that affects muscles and other organs in the body; and Duchenne muscular mystrophy that occurs primarily in boys, as well as to treat diseases associated with various…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Month: March 2017

Unique Cannabis-Pharma Companies Trailblazing the Medical Cannabis Industry

MGX Minerals (MGXMF): Engineering Partner Significantly Upgrades Brine Samples at Lithium Project in Alberta

Cellectar Biosciences, Inc. (NASDAQ: CLRB) Starts Presentation at 29th Annual ROTH Conference

Command Center, Inc. (CCNI) Starts Presentation at 29th Annual ROTH Conference

Extreme Networks, Inc. (NASDAQ: EXTR) Enters Asset Purchase Agreement for Avaya Networking, Subject To Bankruptcy Court Approval

Elio Motors, Inc. (ELIO) Starts Presentation at 29th Annual ROTH Conference

Regulus Therapeutics Inc. (NASDAQ: RGLS) Starts Presentation at 29th Annual Roth Conference

Eastside Distilling, Inc. (ESDI) Starts Presentation at 29th Annual ROTH Conference

Monaker Group Inc (OTCQB:MKGI) Starts Presentation at 29th Annual Roth Conference

Marina Biotech, Inc. (MRNA) Starts Presentation at 29th Annual Roth Conference

NetworkNewsWire Currently Accepts

NetworkNewsWire

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsWire Currently Accepts

Company Search

Site Search